Pre-clinical applications of transgenic mouse mammary cancer models.

Kavanaugh, C J; Desai, K V; Calvo, A; Brown, P H; Couldrey, C; Lubet, R; Green, J E

Kavanaugh, C J; Desai, K V; Calvo, A; Brown, P H; Couldrey, C; Lubet, R; Green, J E.

Affiliation

Kavanaugh CJ; Laboratory of Cellular Regulation and Carcinogenesis, National Cancer Institute, Building 41, Bethesda, MD 20892, USA.

Transgenic Res ; 11(6): 617-33, 2002 Dec.

Article in En | MEDLINE | ID: mdl-12509137

Subject(s)

Antineoplastic Agents/pharmacology; Mammary Neoplasms, Experimental/drug therapy; Angiogenesis Inhibitors; Animals; Antineoplastic Agents/therapeutic use; Cell Cycle/drug effects; Cell Differentiation/drug effects; Drug Evaluation, Preclinical/methods; Female; Immunotherapy; Mammary Neoplasms, Experimental/etiology; Mice; Mice, Transgenic; Signal Transduction/drug effects

Search on Google

Add to My VHL

XML

PubMed Links

Database: MEDLINE Main subject: Mammary Neoplasms, Experimental / Antineoplastic Agents Type of study: Etiology_studies / Prognostic_studies Language: En Journal: Transgenic Res Year: 2002 Type: Article Affiliation country: United States

Search on Google

Add to My VHL

XML

PubMed Links